Condition
Cancer (Advanced Stage)
Total Trials
7
Recruiting
3
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 7 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (2)
Trial Status
Recruiting3
Unknown1
Enrolling By Invitation1
Active Not Recruiting1
Not Yet Recruiting1
Clinical Trials (7)
Showing 7 of 7 trials
NCT07645742Not ApplicableNot Yet RecruitingPrimary
Pilot Study of Intermittent Fasting With Immune Checkpoint Inhibitors
NCT07645261Phase 2RecruitingPrimary
SBRT-LATTICE-PATHY
NCT07639268Not ApplicableEnrolling By InvitationPrimary
Caregivers-Patients Support to Cope With Advanced-Cancer (CASA) Pilot Study.
NCT07584824Recruiting
Is the 1939 Cancer Act Fit for Purpose in the Modern Technology Era?
NCT07468422Active Not Recruiting
Organotypic Platform for Therapeutic Investigation (OPTin) for Guiding Cancer Patients Treatment
NCT07433660Recruiting
WellSpan-THRIVE Cancer QOL Study
NCT00943137Phase 2UnknownPrimary
The Optimization of 5-Fluorouracil Dose by Pharmacokinetic Monitoring in Asian Patients With Advanced Stage Cancer
Showing all 7 trials